GUTSNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
FRACTYL HEALTH, INC.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 10, 2026
$1.38−0.17 (-10.97%)
Close on Oct 19, 2026
- Market cap
- $218.94M
- P/E (TTM)
- –
- Dividend yield
- –
Share price
−$14.10 (−91.09%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.EarningsSplit
FRACTYL HEALTH, INC. saw revenue fall 100.0% to $0 over fiscal 2025. Free cash flow was -$90.89M.
Revenue
$0
-100.0% vs. a year earlier
Operating income
-$85.89M
TTM Q2 2026
Free cash flow
-$90.89M
FY2025
EPS, diluted
-$1.12
TTM Q2 2026
Key statistics
Valuation at the latest close; fundamentals over fiscal 2025, balances at Jun 30, 2026
Valuation
- Market cap
- $218.94M
- P/E ratio
- –
- Price to sales
- –
- Price to book
- –
- Dividend yield
- –
- Free cash flow yield
- -41.51%
Fundamentals
- Revenue
- $0
- Net income
- -$105.65M
- EPS, diluted
- -$1.12
- Free cash flow
- -$90.89M
- Book value per share
- -$0.01
- Diluted shares
- 159M
Four years at a glance
Fiscal years 2022 to 2025 and trailing twelve months, USD
Revenue
–
Gross profit
–
Operating income
-$85.89M
Net income
-$105.65M
EPS, diluted
-$1.12
Free cash flow
–
Reported periodTrailing twelve months